Join the Dermatological Disorders group to help and get support from people like you.
Dermatological Disorders News
Related terms: Skin Conditions
Survey Assesses Perspectives on Patient Image Use in Dermatology
FRIDAY, March 22, 2024 – Most patients report an increase in trust in the quality of their medical care if asked for permission to use their images for research or education, according to a research...
American Academy of Dermatology, March 8 to 12
The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health...
AAD: Concerns Noted Relating to Use of AI Dermatology Apps
FRIDAY, March 8, 2024 – There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published...
Skin of Color Underrepresented in AI Programs in Dermatology
WEDNESDAY, March 6, 2024 – Challenges relating to artificial intelligence (AI) in dermatology and its application to skin of color (SOC) are partly due to underrepresentation of SOC in datasets,...
One in Five New Dermatology Drugs Were First in Class Over the Past Decade
FRIDAY, Dec. 22, 2023 – From 2012 to 2022, innovative dermatologic drug development increased, according to a research letter published online Dec. 20 in JAMA Dermatology. Samir Kamat, M.D., from...
One in Five New Dermatology Drugs Were First in Class Over the Past Decade
FRIDAY, Dec. 22, 2023 (HealthDay News) – From 2012 to 2022, innovative dermatologic drug development increased, according to a research letter published online Dec. 20 in JAMA Dermatology. ...
Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae Care
MONDAY, Dec. 11, 2023 – An educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis barbae (PFB),...
FDA Medwatch Alert: FDA Issues Warning Letters to Three Companies for Selling Unapproved New Drugs for Mole and Skin Tag Removal
August 09, 2022 – Today, the U.S. Food and Drug Administration announced it issued three warning letters to companies for introducing mole and skin tag removal products into interstate commerce that...
FDA Approves Dupixent (dupilumab) for Eczema
March 28, 2017 – The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Acne, Psoriasis, Skin Infection, Urticaria, Hives, Dermatitis, Pruritus, Dry Skin, Seborrheic Dermatitis, view more... Alopecia, Hyperhidrosis, Skin Rash, Lichen Sclerosus, Lichen Planus, Warts, Facial Wrinkles